1.Diagnosis and Management of Congenital Coronary Arteriovenous Fistula in the Pediatric Patients Presenting Congestive Heart Failure and Myocardial Ischemia.
Yonsei Medical Journal 2009;50(1):95-104
PURPOSE: Four pediatric patients with congenital coronary arteriovenous fistula (CAVF) were reported to remind pediatric practitioners and cardiologists of its diagnosis and management. MATERIALS AND METHODS: Four pediatric patients with congenital CAVF from June 1999 to November 2007 were included in this retrospective study. Study modalities included reviews of patients' profiles of clinical features, chest radiograph, Doppler echocardiography, cardiac catheterization with angiography, myocardial perfusion scan, and computed tomography. RESULTS: All 4 patients were symptomatic. The clinical symptoms and signs were feeding problem, continuous murmur, tachycardia, tachypnea, cardiomegaly, and exertional chest pain. Myocardial enzyme was elevated in 1 patient. Echocardiography showed dilatation of the coronary artery in all 4 patients, and traced down its origin in 3 and drainage in 4. The fistulas originated from the right coronary artery in 2 patients and left coronary artery in 2, and were drained into the right ventricle in 2, right atrium in 1, and pulmonary artery in 1. Single left coronary artery was found in 1 patient. The pulmonary-to-systemic blood flow ratios ranged from 1.2 to 2.5. Transcatheter coil occlusion was successfully performed in 4 patients through a coaxial delivery system. The symptoms and signs of congestive heart failure and myocardial ischemia disappeared after the procedure. CONCLUSION: Diagnosis of congenital CAVF could be achieved by appreciation of continuous murmur over area unusual for the ductus, and by scrupulous examination of echocardiography as well as angiography of the coronary artery through which coaxial transcatheter coil occlusion could be performed successfully.
*Arteriovenous Fistula/complications/radiography/therapy
;
Child
;
Child, Preschool
;
Coronary Angiography
;
Coronary Circulation
;
*Coronary Vessel Anomalies/complications/radiography/therapy
;
*Embolization, Therapeutic
;
Female
;
*Heart Failure/etiology/radiography/therapy
;
Humans
;
Infant
;
Male
;
*Myocardial Ischemia/etiology/radiography/therapy
2.Seven-Year Clinical Outcomes of Sirolimus-Eluting Stent Versus Bare-Metal Stent: A Matched Analysis From A Real World, Single Center Registry.
Ung KIM ; Jong Seon PARK ; Sang Hee LEE ; Dong Gu SHIN ; Young Jo KIM
Journal of Korean Medical Science 2013;28(3):396-401
The aim of this study is to compare clinical outcomes for seven years, between sirolimus-eluting stent (SES) and bare metal stent (BMS). During the BMS and drug-eluting stent (DES) transition period (from April 2002 to April 2004), 434 consecutive patients with 482 lesions underwent percutaneous coronary intervention, using BMS or SES. Using propensity score matching, 186 patients with BMS and 166 patients with SES were selected. Seven year clinical outcomes of major adverse cardiac events (MACE), such as cardiac death, myocardial infarction (MI) and ischemia-driven target vessel revascularization (TVR), and angiographic definite stent thrombosis (ST) were compared. At one-year follow up, patients with SES showed significantly lower MACE (9.1% in BMS vs 3.0% in SES, P = 0.024). However, cumulative MACE for 7 yr was not significantly different between two groups (24.7% in BMS vs 17.4% in SES, P = 0.155). There was no significant difference in MI, TVR, death and ST. The TVR were gradually increased from 1 to 7 yr in SES, on the contrary to that of BMS. In conclusion, although SES showed better clinical outcomes in the early period after implantation, it did not show significant benefits in the long-term follow up, compared with that of BMS.
Aged
;
Angioplasty, Balloon, Coronary/adverse effects/*methods
;
Coronary Angiography
;
Coronary Stenosis/mortality/radiography/*therapy
;
Databases, Factual
;
*Drug-Eluting Stents
;
Female
;
Follow-Up Studies
;
Humans
;
Ischemia/etiology
;
Kaplan-Meier Estimate
;
Male
;
Middle Aged
;
Myocardial Infarction/etiology
;
Myocardial Revascularization
;
Registries
;
Sirolimus/*therapeutic use
;
*Stents
;
Thrombosis/etiology
3.Successful Treatment of Ischemic Dysfunction of the Sinus Node with Thrombolytic Therapy: A Case Report.
Jong Seon PARK ; Dong Gu SHIN ; Young Jo KIM ; Gu Ru HONG ; Hyung Jun KIM ; Bong Sup SHIM
The Korean Journal of Internal Medicine 2006;21(4):283-286
We report on a case of ischemic dysfunction of the sinus node as a complication after percutaneous transluminal coronary angioplasty of the distal left circumflex artery. After local thrombolytic therapy in the sinus node artery, sinus node arterial flow was re-established and sinus node function normalized over the period of a week. Our experience suggests that immediate reperfusion of a totally occluded nodal artery can be re-established. Ischemic dysfunction of the sinus node, as a complication of angioplasty, is generally transient and requires a prolonged period for recovery. Therefore the decision to implant a permanent pacemaker should be delayed for at least one week after the ischemic insult.
Urinary Plasminogen Activator/administration & dosage/*therapeutic use
;
Thrombolytic Therapy/*methods
;
Sinoatrial Node/*physiopathology
;
Myocardial Ischemia/*complications/radiography/therapy
;
Middle Aged
;
Male
;
Infusions, Intravenous
;
Humans
;
Follow-Up Studies
;
Fibrinolytic Agents/administration & dosage/*therapeutic use
;
Electrocardiography
;
Coronary Angiography
;
Arrhythmia/diagnosis/*drug therapy/etiology
;
Angioplasty, Transluminal, Percutaneous Coronary/adverse effects